Patterson Matthew R

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Audentes Therapeutics Inc (BOLD)

Transaction date 25 Feb 2019

Planned sale

Price

366.01

Quantity 71,017 +40.7%

Value US$2,908,197

Comments Filing

Audentes Therapeutics Inc (BOLD)

Transaction date 25 Feb 2019

Planned sale

Price

332.16

Quantity 77,609 -48.9%

Value US$3,514,713

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2019-02-27	2019-02-25	Audentes Therapeutics Inc (BOLD)	PlS Planned sale	71,017 +40.7% 366.01 US$2,908,197	71,017 +40.7%	366.01	US$2,908,197
2019-02-27	2019-02-25	Audentes Therapeutics Inc (BOLD)	PlS Planned sale	77,609 -48.9% 332.16 US$3,514,713	77,609 -48.9%	332.16	US$3,514,713